‎Singapore: Miltenyi Biotec, a cell innovation company, has opened a new office in Seoul, South Korea, enlarging the company's Asia Pacific presence to six locations in five countries.

"Miltenyi Biotec recognizes the potential of a Korean presence in achieving strong, steady growth and expanding our global reach with a team of talented people," said Mr Boris Stoffel, CEO, Miltenyi Biotec. "Our new team has an exceptional ability to partner with scientists and clinicians to generate exciting opportunities."

Mr Daesuk Oh has been appointed general manager of the new office in the Gangnam district of Seoul. "Our location will be instrumental in developing deeper relationships with a host of stem cell, immunology, translational research, and clinical customers, as well as prospective research and clinical institutions throughout South Korea," Mr Oh.

"We're excited for the opportunity to bring Miltenyi Biotec's solutions to scientists and clinicians who can truly benefit from the quality and reliability the portfolio is known for," said Mr Oh.

Miltenyi Biotec is a global provider of products and services that advance biomedical research. The company's integrated portfolio of tools supports the translation of basic research into practical applications for human health.